Javier Torres Valencia, MD, MSc
@torres_valj
Clinical Cardiologist / Epidemiologist 🇵🇪. Universidad Peruana Cayetano Heredia. Hospital Nacional Edgardo Rebagliati Martins.
ID: 973857734318673920
https://orcid.org/0000-0002-0941-677X 14-03-2018 09:45:52
322 Tweet
255 Takipçi
405 Takip Edilen
#JADEL Just dropped in CASE: doi.org/10.1016/j.case… 70M with acute dyspnea during COVID-19.... A. AMI with septal rupture B. HFrEF C. COVID Pneumonia D. Something else American Society of Echocardiography CV Case Journal
Our March 2025 CV Case Journal is online! bit.ly/4hQ4Ef6 The issue features: 💙Infective Endocarditis of the Autograft and the Neo–Aortic Root Following the Ross Operation 💙Tricuspid Valve Blood Cysts on Intracardiac Echo 💙An Exceptionally Large Papillary Fibroelastoma
🫀 Rare cardiac complication during COVID-19: A 70-year-old man with missed MI developed a VSR and left ventricular aneurysm. TTE was crucial in diagnosis and surgical management. Case in CV Case Journal #echofirst | doi: doi.org/10.1016/j.case…
Excited to present a case on a topic I am truly passionate about. Looking forward to seeing everyone at #ACC25 tomorrow! American College of Cardiology
The best that ACC has given me. Nice to meet you, great people. Johanna Contreras, MD, MSc Luis Sanchez-Ato, M.D. Carlos Espiche MD MEd César Joel Benites Moya Daniel Mendoza-Quispe, MD, MSc Victor Becerra Antony Gonzales, MD Juan Manuel Muñoz-Moreno, MD, FACC Gina L. Sanchez-Sanchez
Thrilled to share our clinical cases from Rebagliati Hospital at #ACC25, where we showcased our experience in Peru 🇵🇪. Thank you to my colleagues, residents, and mentors for their support. American College of Cardiology JACC Journals
Amyloidosis Mysteries: Cracking the Toughest Cases 📅 Tuesday, May 13, 2025 12:00 PM EDT Join us for an engaging online case study session with insights from expert discussions on diagnosing of amyloidosis. #MedicalEducation #Amyloidosis #ISA_Amyloidosis isaamyloidosis.org/2025-may-case-…
Register today to the Postgraduate Course on Periprocedural #Echofirst course in London 🇬🇧 organised by CardioTomLuscher Alison Duncan avazir with national & international faculty - endorsed by BSEcho EACVI President with Fabien Praz francesco maisano Denisa Muraru @MadalinaGarbi and
BU Amyloidosis Center Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint (HR=0.915, p-value=0.76). In addition, neither of the secondary endpoints were met: 6MWD (nominal p-value=0.52) and SF-36 PCS Score (nominal p-value=0.95).
